160 related articles for article (PubMed ID: 35630817)
1. Computer-Aided Detection of Quantitative Signatures for Breast Fibroepithelial Tumors Using Label-Free Multi-Photon Imaging.
Kobayashi-Taguchi K; Saitou T; Kamei Y; Murakami A; Nishiyama K; Aoki R; Kusakabe E; Noda H; Yamashita M; Kitazawa R; Imamura T; Takada Y
Molecules; 2022 May; 27(10):. PubMed ID: 35630817
[TBL] [Abstract][Full Text] [Related]
2. Second harmonic generation microscopy is a novel technique for differential diagnosis of breast fibroepithelial lesions.
Tan WJ; Yan J; Xu S; Thike AA; Bay BH; Yu H; Tan MH; Tan PH
J Clin Pathol; 2015 Dec; 68(12):1033-5. PubMed ID: 26209730
[TBL] [Abstract][Full Text] [Related]
3. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
4. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
5. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
6. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
7. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor.
Cheng CL; Md Nasir ND; Ng GJZ; Chua KWJ; Li Y; Rodrigues J; Thike AA; Heng SY; Koh VCY; Lim JX; Hiew VJN; Shi R; Tan BY; Tay TKY; Ravi S; Ng KH; Oh KSL; Tan PH
Lab Invest; 2022 Mar; 102(3):245-252. PubMed ID: 34819630
[TBL] [Abstract][Full Text] [Related]
9. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
[TBL] [Abstract][Full Text] [Related]
10. A Diagnostic Approach to Fibroepithelial Breast Lesions.
Tan BY; Tan PH
Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
[TBL] [Abstract][Full Text] [Related]
11. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
12. Native T1 mapping of the breast in MRI to differentiate fibroadenomas from benign phyllodes tumors: a preliminary study.
Yalcin A; Goktepeli M; Taydas O; Sayar I
MAGMA; 2022 Jun; 35(3):441-447. PubMed ID: 34727247
[TBL] [Abstract][Full Text] [Related]
13. Differential cytologic features of fibroepithelial lesions of the breast.
Deen SA; McKee GT; Kissin MW
Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
Bode MK; Rissanen T; Apaja-Sarkkinen M
Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
[TBL] [Abstract][Full Text] [Related]
15. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
[TBL] [Abstract][Full Text] [Related]
16. Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology?
Scolyer RA; McKenzie PR; Achmed D; Lee CS
Pathology; 2001 Nov; 33(4):437-43. PubMed ID: 11827409
[TBL] [Abstract][Full Text] [Related]
17. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
18. [Fibroepithelial tumours of the breast: not always a simple fibroadenoma].
van de Graaf VA; de Raaff CAL; Walter AW; Weimann MN; Vrouenraets BC
Ned Tijdschr Geneeskd; 2017; 161():D886. PubMed ID: 28466794
[TBL] [Abstract][Full Text] [Related]
19. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
Resetkova E; Khazai L; Albarracin CT; Arribas E
Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
[TBL] [Abstract][Full Text] [Related]
20. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy.
Wiratkapun C; Piyapan P; Lertsithichai P; Larbcharoensub N
Diagn Interv Radiol; 2014; 20(1):27-33. PubMed ID: 24356293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
